Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Description

Lorlatinib is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has spread to other parts of our body. In today's episode we have discussed how it works, who are the eligible for the same and the common side effects of the drug. We hope this helps. See you soon. Jai Hind

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.